MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells

FEBS Journal

Volumn 276, Issue 22, 2009, Pages 6689-6700

  Borralho, Pedro M ^a   Kren, Betsy T ^b   Castro, Rui E ^a   Moreira Da Silva, Isabel B ^a   Steer, Clifford J ^a,b   Rodrigues, Cecília M P ^a  

^a UNIVERSITY OF LISBON   (Portugal)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

5 fluorouracil; Apoptosis; Chemosensitizer; ERK5; MiR 143

Indexed keywords

ANTIBIOTIC G 418; CASPASE 3; CASPASE 8; CASPASE 9; FLUOROURACIL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; MICRORNA 143; MITOGEN ACTIVATED PROTEIN KINASE 7; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CELL SYNCHRONIZATION; CELL VIABILITY; CHEMOSENSITIVITY; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; DRUG EXPOSURE; DRUG SENSITIVITY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ANTIMETABOLITES; APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CASPASE 8; CASPASE 9; CELL SURVIVAL; DRUG RESISTANCE, NEOPLASM; FLUOROURACIL; HCT116 CELLS; HUMANS; MICRORNAS; MITOGEN-ACTIVATED PROTEIN KINASE 7; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 70350433121     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2009.07383.x     Document Type: Article

References (31)

1. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281 297.
2. Carthew RW (2006) Gene regulation by microRNAs. Curr Opin Genet Dev 16, 203 208.
3. Michael MZ, SM OC, van Holst Pellekaan NG, Young GP James RJ (2003) Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 1, 882 891.
4. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103, 2257 2261.
5. Akao Y, Nakagawa Y Naoe T (2006) MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers. Oncol Rep 16, 845 850.
6. Akao Y, Nakagawa Y, Kitade Y, Kinoshita T Naoe T (2007) Downregulation of microRNAs-143 and -145 in B-cell malignancies. Cancer Sci 98, 1914 1920.
7. Lin T, Dong W, Huang J, Pan Q, Fan X, Zhang C Huang L (2009) MicroRNA-143 as a tumor suppressor for bladder cancer. J Urol 181, 1372 1380.
8. Lui WO, Pourmand N, Patterson BK Fire A (2007) Patterns of known and novel small RNAs in human cervical cancer. Cancer Res 67, 6031 6043.
9. Esau C, Kang X, Peralta E, Hanson E, Marcusson EG, Ravichandran LV, Sun Y, Koo S, Perera RJ, Jain R et al. (2004) MicroRNA-143 regulates adipocyte differentiation. J Biol Chem 279, 52361 52365.
10. Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S Miyazono K (2009) Modulation of microRNA processing by p53. Nature 460, 529 533.
11. Chen X, Guo X, Zhang H, Xiang Y, Chen J, Yin Y, Cai X, Wang K, Wang G, Ba Y et al. (2009) Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene 28, 1385 1392.
12. Akao Y, Nakagawa Y, Iio A Naoe T (2009) Role of microRNA-143 in Fas-mediated apoptosis in human T-cell leukemia Jurkat cells. Leuk Res 33, 1530 1538.
13. Ng EK, Tsang WP, Ng SS, Jin HC, Yu J, Li JJ, Rocken C, Ebert MP, Kwok TT Sung JJ (2009) MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. Br J Cancer 101, 699 706.
14. Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN, Lee TH, Miano JM, Ivey KN Srivastava D (2009) miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460, 705 710.
15. Wang X Tournier C (2006) Regulation of cellular functions by the ERK5 signalling pathway. Cell Signal 18, 753 760.
16. Pearson G, English JM, White MA Cobb MH (2001) ERK5 and ERK2 cooperate to regulate NF-κB and cell transformation. J Biol Chem 276, 7927 7931.
17. Cude K, Wang Y, Choi HJ, Hsuan SL, Zhang H, Wang CY Xia Z (2007) Regulation of the G2-M cell cycle progression by the ERK5-NFκB signaling pathway. J Cell Biol 177, 253 264.
18. Yu YY, Li Q Zhu ZG (2005) NF-κB as a molecular target in adjuvant therapy of gastrointestinal carcinomas. Eur J Surg Oncol 31, 386 392.
19. Longley DB, Harkin DP Johnston PG (2003) 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 3, 330 338.
20. Borralho PM, Moreira da Silva IB, Aranha MM, Albuquerque C, Nobre Leitao C, Steer CJ Rodrigues CM (2007) Inhibition of Fas expression by RNAi modulates 5-fluorouracil-induced apoptosis in HCT116 cells expressing wild-type p53. Biochim Biophys Acta 1772, 40 47.
21. Longley DB, Allen WL, McDermott U, Wilson TR, Latif T, Boyer J, Lynch M Johnston PG (2004) The roles of thymidylate synthase and p53 in regulating Fas-mediated apoptosis in response to antimetabolites. Clin Cancer Res 10, 3562 3571.
22. Rossi L, Bonmassar E Faraoni I (2007) Modification of miR gene expression pattern in human colon cancer cells following exposure to 5-fluorouracil in vitro. Pharmacol Res 56, 248 253.
23. Petit E, Milano G, Levi F, Thyss A, Bailleul F Schneider M (1988) Circadian rhythm-varying plasma concentration of 5-fluorouracil during a five-day continuous venous infusion at a constant rate in cancer patients. Cancer Res 48, 1676 1679.
24. Nakajima G, Hayashi K, Xi Y, Kudo K, Uchida K, Takasaki K, Yamamoto M Ju J (2006) Non-coding microRNAs hsa-let-7g and hsa-miR-181b are associated with chemoresponse to S-1 in colon cancer. Cancer Genomics Proteomics 3, 317 324.
25. Takagi T, Iio A, Nakagawa Y, Naoe T, Tanigawa N Akao Y (2009) Decreased expression of microRNA-143 and -145 in human gastric cancers. Oncology 77, 12 21.
26. Sachdeva M, Zhu S, Wu F, Wu H, Walia V, Kumar S, Elble R, Watabe K Mo YY (2009) p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci USA 106, 3207 3212.
27. Akao Y, Nakagawa Y Naoe T (2007) MicroRNA-143 and -145 in colon cancer. DNA Cell Biol 26, 311 320.
28. Nishimoto S Nishida E (2006) MAPK signalling: ERK5 versus ERK1/2. EMBO Rep 7, 782 786.
29. Pi X, Yan C Berk BC (2004) Big mitogen-activated protein kinase (BMK1)/ERK5 protects endothelial cells from apoptosis. Circ Res 94, 362 369.
30. Girio A, Montero JC, Pandiella A Chatterjee S (2007) Erk5 is activated and acts as a survival factor in mitosis. Cell Signal 19, 1964 1972.
31. Nakagawa Y, Iinuma M, Naoe T, Nozawa Y Akao Y (2007) Characterized mechanism of alpha-mangostin-induced cell death: caspase-independent apoptosis with release of endonuclease-G from mitochondria and increased miR-143 expression in human colorectal cancer DLD-1 cells. Bioorg Med Chem 15, 5620 5628.